ARCHIVES

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

DCT Board Okays Recompetition of Drug Discovery Groups

October 22, 1993

Garb Points Out Cancer Program Is Saving ore Lives a Year Than Polio Vaccine

April 6, 1979

Salick Signs contract for Fixed-Price Oncology Services

April 1, 1994

PBS Runs Misleading Lung Screening Claim; Reporter and Subject on Mount Sinai Faculty

October 11, 2013

Age Doesn’t Affect Survival After Bone Marrow Transplant

December 26, 2008

Greenwald: Report’s Implementation Will Require Budget Raise

June 27, 1997